{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:44:08Z","timestamp":1792143848432,"version":"4.4.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03099-1","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:36:14Z","timestamp":1784694974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The mevalonate and methylerythritol phosphate pathways as therapeutic targets in protozoan parasites: from moonlighting enzymes to metabolic plasticity"],"prefix":"10.1186","volume":"24","author":[{"given":"Reza","family":"Mansouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Alcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Gavino-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Manzano-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"crossref","unstructured":"Tang H, Xue G. Major physiological signaling pathways in the regulation of cell proliferation and survival. Mechanisms of Drug Resistance in Cancer Therapy. Springer; 2017. p. 13\u201330.","DOI":"10.1007\/164_2017_4"},{"key":"3099_CR2","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3390\/ijms20133292","volume":"20","author":"A Nair","year":"2019","unstructured":"Nair A, Chauhan P, Saha B, Kubatzky KF. Conceptual evolution of cell signaling. Int J Mol Sci. 2019;20:3292.","journal-title":"Int J Mol Sci"},{"key":"3099_CR3","doi-asserted-by":"crossref","first-page":"a040600","DOI":"10.1101\/cshperspect.a040600","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel NS. Signaling and metabolism. Cold Spring Harb Perspect Biol. 2021;13:a040600.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"3099_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrg3055","volume":"12","author":"E De Nadal","year":"2011","unstructured":"De Nadal E, Ammerer G, Posas F. Controlling gene expression in response to stress. Nat Rev Genet. 2011;12:833\u201345.","journal-title":"Nat Rev Genet"},{"key":"3099_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","volume":"16","author":"R Santos","year":"2017","unstructured":"Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI. A comprehensive map of molecular drug targets. Nat Rev Drug Discovery. 2017;16:19\u201334.","journal-title":"Nat Rev Drug Discovery"},{"key":"3099_CR6","doi-asserted-by":"crossref","first-page":"e00164","DOI":"10.1128\/mmbr.00164-22","volume":"88","author":"S Ewald","year":"2024","unstructured":"Ewald S, Nasuhidehnavi A, Feng T-Y, Lesani M, McCall L-I. The intersection of host in vivo metabolism and immune responses to infection with kinetoplastid and apicomplexan parasites. Microbiol Mol Biol Rev. 2024;88:e00164\u201300122.","journal-title":"Microbiol Mol Biol Rev"},{"key":"3099_CR7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.15698\/mic2021.11.764","volume":"8","author":"GP de Aquino","year":"2021","unstructured":"de Aquino GP, Gomes MAM, Salinas RK, Laranjeira-Silva MF. Lipid and fatty acid metabolism in trypanosomatids. Microb Cell. 2021;8:262.","journal-title":"Microb Cell"},{"key":"3099_CR8","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s00018-009-0086-3","volume":"66","author":"S Kostenko","year":"2009","unstructured":"Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci. 2009;66:3289\u2013307.","journal-title":"Cell Mol Life Sci"},{"key":"3099_CR9","doi-asserted-by":"publisher","unstructured":"Prasanna P, Upadhyay A. Heat shock proteins as the druggable targets in leishmaniasis: promises and perils. Infect Immun. 2021;89. https:\/\/doi.org\/10.1128\/iai.00559-00520.","DOI":"10.1128\/iai.00559-00520"},{"key":"3099_CR10","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1074\/jbc.RA120.014587","volume":"295","author":"S Das","year":"2020","unstructured":"Das S, Banerjee A, Kamran M, Ejazi SA, Asad M, Ali N, Chakrabarti S. A chemical inhibitor of heat shock protein 78 (HSP78) from Leishmania donovani represents a potential antileishmanial drug candidate. J Biol Chem. 2020;295:9934\u201347.","journal-title":"J Biol Chem"},{"key":"3099_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1051\/parasite\/2025001","volume":"32","author":"Y Lu","year":"2025","unstructured":"Lu Y, Zhang X, Guan Z, Ji R, Peng F, Zhao C, Gao W, Gao F. Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions. Parasite. 2025;32:7.","journal-title":"Parasite"},{"key":"3099_CR12","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/acsinfecdis.4c00323","volume":"10","author":"D Liu","year":"2024","unstructured":"Liu D, Bhunia AK. Anchorless bacterial moonlighting metabolic enzymes modulate the immune system and contribute to pathogenesis. ACS Infect Dis. 2024;10:2551\u201366.","journal-title":"ACS Infect Dis"},{"key":"3099_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1590\/S0074-02762011000900011","volume":"106","author":"AK Ghosh","year":"2011","unstructured":"Ghosh AK, Jacobs-Lorena M. Surface-expressed enolases of Plasmodium and other pathogens. Mem Inst Oswaldo Cruz. 2011;106:85\u201390.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"3099_CR14","doi-asserted-by":"crossref","first-page":"e1005606","DOI":"10.1371\/journal.ppat.1005606","volume":"12","author":"KE Swearingen","year":"2016","unstructured":"Swearingen KE, Lindner SE, Shi L, Shears MJ, Harupa A, Hopp CS, Vaughan AM, Springer TA, Moritz RL, Kappe SH. Interrogating the Plasmodium sporozoite surface: identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathog. 2016;12:e1005606.","journal-title":"PLoS Pathog"},{"key":"3099_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1475-2875-6-45","volume":"6","author":"I Pal-Bhowmick","year":"2007","unstructured":"Pal-Bhowmick I, Vora HK, Jarori GK. Sub-cellular localization and post-translational modifications of the Plasmodium yoelii enolase suggest moonlighting functions. Malar J. 2007;6:45.","journal-title":"Malar J"},{"key":"3099_CR16","doi-asserted-by":"crossref","first-page":"107195","DOI":"10.1016\/j.phrs.2024.107195","volume":"204","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang J, Shan C. The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies. Pharmacol Res. 2024;204:107195.","journal-title":"Pharmacol Res"},{"key":"3099_CR17","doi-asserted-by":"crossref","unstructured":"Rojas-Pirela M, Andrade-Alvi\u00e1rez D, Rojas V, Marcos M, Salete-Granado D, Chac\u00f3n-Arnaude M, P\u00e9rez-Nieto M\u00c1, Kemmerling U, Concepci\u00f3n JL, Michels PA. Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections. Open Biol. 2025;15:240239.","DOI":"10.1098\/rsob.240239"},{"key":"3099_CR18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2174\/1871520623666221020092423","volume":"23","author":"S Wang","year":"2023","unstructured":"Wang S, Zhuang Y, Xu J, Tong Y, Li X, Dong C. Advances in the study of hexokinase 2 (HK2) inhibitors. Anti-Cancer Agents Med Chemistry-Anti-Cancer Agents). 2023;23:736\u201346.","journal-title":"Anti-Cancer Agents Med Chemistry-Anti-Cancer Agents)"},{"key":"3099_CR19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/138161207780162827","volume":"13","author":"A Gangjee","year":"2007","unstructured":"Gangjee A, Kurup S, Namjoshi O. Dihydrofolate reductase as a target for chemotherapy in parasites. Curr Pharm Design. 2007;13:609\u201339.","journal-title":"Curr Pharm Design"},{"key":"3099_CR20","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1074\/jbc.273.6.3461","volume":"273","author":"MG Reynolds","year":"1998","unstructured":"Reynolds MG, Roos DS. A biochemical and genetic model for parasite resistance to antifolates: Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum. J Biol Chem. 1998;273:3461\u20139.","journal-title":"J Biol Chem"},{"key":"3099_CR21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/0035-9203(85)90195-6","volume":"79","author":"S Van Nieuwenhove","year":"1985","unstructured":"Van Nieuwenhove S, Schechter P, Declercq J, Bone G, Burke J, Sjoerdsma A. Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-\u03b1-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial. Trans R Soc Trop Med Hyg. 1985;79:692\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"3099_CR22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9343(87)90107-0","volume":"82","author":"H Taelman","year":"1987","unstructured":"Taelman H, Schechter PJ, Marcelis L, Sonnet J, Kazyumba G, Dasnoy J, Haegele KD, Sjoerdsma A, Wery M. Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis: results in five patients. Am J Med. 1987;82:607\u201314.","journal-title":"Am J Med"},{"key":"3099_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1475-2875-12-91","volume":"12","author":"N Chaianantakul","year":"2013","unstructured":"Chaianantakul N, Sirawaraporn R, Sirawaraporn W. Insights into the role of the junctional region of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase. Malar J. 2013;12:91.","journal-title":"Malar J"},{"key":"3099_CR24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cbpa.2010.05.005","volume":"14","author":"V Barton","year":"2010","unstructured":"Barton V, Fisher N, Biagini GA, Ward SA, O\u2019Neill PM. Inhibiting Plasmodium cytochrome bc1: a complex issue. Curr Opin Chem Biol. 2010;14:440\u20136.","journal-title":"Curr Opin Chem Biol"},{"key":"3099_CR25","doi-asserted-by":"crossref","first-page":"ra296111","DOI":"10.1126\/scitranslmed.aaa6645","volume":"7","author":"MA Phillips","year":"2015","unstructured":"Phillips MA, Lotharius J, Marsh K, White J, Dayan A, White KL, Njoroge JW, El Mazouni F, Lao Y, Kokkonda S. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci Transl Med. 2015;7:ra296111\u2013296111.","journal-title":"Sci Transl Med"},{"key":"3099_CR26","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S1473-3099(18)30309-8","volume":"18","author":"A Llanos-Cuentas","year":"2018","unstructured":"Llanos-Cuentas A, Casapia M, Chuquiyauri R, Hinojosa J-C, Kerr N, Rosario M, Toovey S, Arch RH, Phillips MA, Rozenberg FD. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Lancet Infect Dis. 2018;18:874\u201383.","journal-title":"Lancet Infect Dis"},{"key":"3099_CR27","doi-asserted-by":"crossref","first-page":"114623","DOI":"10.1016\/j.bcp.2021.114623","volume":"196","author":"MA Lasunci\u00f3n","year":"2022","unstructured":"Lasunci\u00f3n MA, Mart\u00ednez-Botas J, Mart\u00edn-S\u00e1nchez C, Busto R, G\u00f3mez-Coronado D. Cell cycle dependence on the mevalonate pathway: Role of cholesterol and non-sterol isoprenoids. Biochem Pharmacol. 2022;196:114623.","journal-title":"Biochem Pharmacol"},{"key":"3099_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1568026616666160719164542","volume":"17","author":"A Gordon","year":"2017","unstructured":"Gordon A, Fishwick JWG, McPhillie CJ. New opportunities in the structure-based design of anti-protozoan agents. Curr Top Med Chem. 2017;17:79\u201390.","journal-title":"Curr Top Med Chem"},{"key":"3099_CR29","doi-asserted-by":"crossref","first-page":"e73208","DOI":"10.7554\/eLife.73208","volume":"11","author":"M Okada","year":"2022","unstructured":"Okada M, Rajaram K, Swift RP, Mixon A, Maschek JA, Prigge ST, Sigala PA. Critical role for isoprenoids in apicoplast biogenesis by malaria parasites. Elife. 2022;11:e73208.","journal-title":"Elife"},{"key":"3099_CR30","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","volume":"9","author":"E Yeh","year":"2011","unstructured":"Yeh E, DeRisi JL. Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum. PLoS Biol. 2011;9:e1001138.","journal-title":"PLoS Biol"},{"key":"3099_CR31","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","volume":"285","author":"H Jomaa","year":"1999","unstructured":"Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M, Turbachova I, Eberl M, Zeidler J, Lichtenthaler HK. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science. 1999;285:1573\u20136.","journal-title":"Science"},{"key":"3099_CR32","doi-asserted-by":"crossref","first-page":"21573","DOI":"10.1074\/jbc.R700005200","volume":"282","author":"WN Hunter","year":"2007","unstructured":"Hunter WN. The non-mevalonate pathway of isoprenoid precursor biosynthesis. J Biol Chem. 2007;282:21573\u20137.","journal-title":"J Biol Chem"},{"key":"3099_CR33","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/molecules24203721","volume":"24","author":"IB Verdaguer","year":"2019","unstructured":"Verdaguer IB, Zafra CA, Crispim M, Sussmann RA, Kimura EA, Katzin AM. Prenylquinones in human parasitic protozoa: Biosynthesis, physiological functions, and potential as chemotherapeutic targets. Molecules. 2019;24:3721.","journal-title":"Molecules"},{"key":"3099_CR34","doi-asserted-by":"crossref","first-page":"19250","DOI":"10.1016\/S0021-9258(18)54990-5","volume":"266","author":"P L\u00f6w","year":"1991","unstructured":"L\u00f6w P, Dallner G, Mayor S, Cohen S, Chait B, Menon A. The mevalonate pathway in the bloodstream form of Trypanosoma brucei. Identification of dolichols containing 11 and 12 isoprene residues. J Biol Chem. 1991;266:19250\u20137.","journal-title":"J Biol Chem"},{"key":"3099_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpara.2008.08.012","volume":"39","author":"J Carrero-L\u00e9rida","year":"2009","unstructured":"Carrero-L\u00e9rida J, P\u00e9rez-Moreno G, Castillo-Acosta VM, Ruiz-P\u00e9rez LM, Gonz\u00e1lez-Pacanowska D. Intracellular location of the early steps of the isoprenoid biosynthetic pathway in the trypanosomatids Leishmania major and Trypanosoma brucei. Int J Parasitol. 2009;39:307\u201314.","journal-title":"Int J Parasitol"},{"key":"3099_CR36","doi-asserted-by":"crossref","first-page":"24610","DOI":"10.1038\/srep24610","volume":"6","author":"\u00c9R Ferreira","year":"2016","unstructured":"Ferreira \u00c9R, Horjales E, Bonfim-Melo A, Cortez C, da Silva CV, De Groote M, Sobreira TJP, Cruz MC, Lima FM, Cordero EM. Unique behavior of Trypanosoma cruzi mevalonate kinase: a conserved glycosomal enzyme involved in host cell invasion and signaling. Sci Rep. 2016;6:24610.","journal-title":"Sci Rep"},{"key":"3099_CR37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3389\/fcimb.2017.00426","volume":"7","author":"D Bahia","year":"2017","unstructured":"Bahia D. A new trick for a conserved enzyme: mevalonate kinase, a glycosomal enzyme, can be secreted by Trypanosoma cruzi and modulate cell invasion and signaling. Is it another moonlighting enzyme? Front Cell Infect Microbiol. 2017;7:426.","journal-title":"Front Cell Infect Microbiol"},{"key":"3099_CR38","doi-asserted-by":"crossref","first-page":"126837","DOI":"10.1016\/j.micres.2021.126837","volume":"251","author":"MT Shafi","year":"2021","unstructured":"Shafi MT, Bamra T, Das S, Kumar A, Abhishek K, Kumar M, Kumar V, Kumar A, Mukherjee R, Sen A. Mevalonate kinase of Leishmania donovani protects parasite against oxidative stress by modulating ergosterol biosynthesis. Microbiol Res. 2021;251:126837.","journal-title":"Microbiol Res"},{"key":"3099_CR39","doi-asserted-by":"crossref","first-page":"641985","DOI":"10.3389\/fcimb.2021.641985","volume":"11","author":"T Bamra","year":"2021","unstructured":"Bamra T, Shafi T, Das S, Kumar M, Dikhit MR, Kumar A, Kumar A, Abhishek K, Pandey K, Sen A. Leishmania donovani secretory mevalonate kinase regulates host immune response and facilitates phagocytosis. Front Cell Infect Microbiol. 2021;11:641985.","journal-title":"Front Cell Infect Microbiol"},{"key":"3099_CR40","doi-asserted-by":"crossref","unstructured":"Dikhit MR, Kayet P, Basak S, Ganguly S, Das P. Structural Insights into Leishmania donovani Mevalonate Kinase and Its Interaction with Toll-Like Receptors During Early Infection. Acta Trop 2025;270:107774.","DOI":"10.1016\/j.actatropica.2025.107774"},{"key":"3099_CR41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molbiopara.2019.03.001","volume":"230","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Basu S, Zhang K. Farnesyl pyrophosphate synthase is essential for the promastigote and amastigote stages in Leishmania major. Mol Biochem Parasitol. 2019;230:8\u201315.","journal-title":"Mol Biochem Parasitol"},{"key":"3099_CR42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines9020105","volume":"9","author":"A Pance","year":"2021","unstructured":"Pance A. The stem cell revolution revealing protozoan parasites\u2019 secrets and paving the way towards vaccine development. Vaccines. 2021;9:105.","journal-title":"Vaccines"},{"key":"3099_CR43","doi-asserted-by":"crossref","first-page":"24223","DOI":"10.1074\/jbc.M100951200","volume":"276","author":"IJ Blader","year":"2001","unstructured":"Blader IJ, Manger ID, Boothroyd JC. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J Biol Chem. 2001;276:24223\u201331.","journal-title":"J Biol Chem"},{"key":"3099_CR44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2019.05.005","volume":"60","author":"M Knight","year":"2019","unstructured":"Knight M, Stanley S. HIF-1\u03b1 as a central mediator of cellular resistance to intracellular pathogens. Curr Opin Immunol. 2019;60:111\u20136.","journal-title":"Curr Opin Immunol"},{"key":"3099_CR45","first-page":"457","volume":"68","author":"J Dzik","year":"2021","unstructured":"Dzik J. Metabolic evolutionary roots of the macrophage immune response in amoeba-bacteria interactions: the conserved role of hypoxia-induced factor and AMP kinase. Acta Biochim Pol. 2021;68:457\u201376.","journal-title":"Acta Biochim Pol"},{"key":"3099_CR46","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1038\/ncomms5467","volume":"5","author":"AM Guggisberg","year":"2014","unstructured":"Guggisberg AM, Park J, Edwards RL, Kelly ML, Hodge DM, Tolia NH, Odom AR. A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites. Nat Commun. 2014;5:4467.","journal-title":"Nat Commun"},{"key":"3099_CR47","doi-asserted-by":"crossref","unstructured":"Henkel S, Frohnecke N, Maus D, McConville MJ, Laue M, Blume M, Seeber F. Toxoplasma gondii apicoplast-resident ferredoxin is an essential electron transfer protein for the MEP isoprenoid-biosynthetic pathway. J Biol Chem. 2022;298:101468.","DOI":"10.1016\/j.jbc.2021.101468"},{"key":"3099_CR48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0166-6851(94)00070-4","volume":"72","author":"HD Luj\u00e1n","year":"1995","unstructured":"Luj\u00e1n HD, Mowatt MR, Chen G-Z, Nash TE. Isoprenylation of proteins in the protozoan Giardia lamblia. Mol Biochem Parasitol. 1995;72:121\u20137.","journal-title":"Mol Biochem Parasitol"},{"key":"3099_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exppara.2017.07.010","volume":"181","author":"NM Taha","year":"2017","unstructured":"Taha NM, Yousof H-ASA, El-Sayed SH, Younis AI, Negm MSI. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice. Exp Parasitol. 2017;181:57\u201369.","journal-title":"Exp Parasitol"},{"key":"3099_CR50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s12639-022-01510-5","volume":"46","author":"AK Dhal","year":"2022","unstructured":"Dhal AK, Panda C, Yun S-I, Mahapatra RK. An update on Cryptosporidium biology and therapeutic avenues. J Parasitic Dis. 2022;46:923\u201339.","journal-title":"J Parasitic Dis"},{"key":"3099_CR51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fcimb.2019.00180","volume":"9","author":"A Probst","year":"2019","unstructured":"Probst A, Nguyen TN, El-Sakkary N, Skinner D, Suzuki BM, Buckner FS, Gelb MH, Caffrey CR, Debnath A. Bioactivity of farnesyltransferase inhibitors against Entamoeba histolytica and Schistosoma mansoni. Front Cell Infect Microbiol. 2019;9:180.","journal-title":"Front Cell Infect Microbiol"},{"key":"3099_CR52","first-page":"71","volume":"18","author":"T Sivakumar","year":"2008","unstructured":"Sivakumar T, Aboulaila M, Khukhuu A, Iseki H, Alhassan A, Yokoyama N, Igarashi I. In vitro inhibitory effect of fosmidomycin on the asexual growth of Babesia bovis and Babesia bigemina. J Protozoology Res. 2008;18:71\u20138.","journal-title":"J Protozoology Res"},{"key":"3099_CR53","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1091\/mbc.e03-10-0720","volume":"15","author":"J Pena-Diaz","year":"2004","unstructured":"Pena-Diaz J, Montalvetti A, Flores C-L, Const\u00e1n A, Hurtado-Guerrero R, De Souza W, Gancedo C, Ruiz-Perez LM, Gonzalez-Pacanowska D. Mitochondrial localization of the mevalonate pathway enzyme 3-Hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae. Mol Biol Cell. 2004;15:1356\u201363.","journal-title":"Mol Biol Cell"},{"key":"3099_CR54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.exppara.2008.02.013","volume":"119","author":"M Ferella","year":"2008","unstructured":"Ferella M, Li Z-H, Andersson B, Docampo R. Farnesyl diphosphate synthase localizes to the cytoplasm of Trypanosoma cruzi and T. brucei. Exp Parasitol. 2008;119:308\u201312.","journal-title":"Exp Parasitol"},{"key":"3099_CR55","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0169-4758(96)10073-9","volume":"12","author":"CE Clayton","year":"1996","unstructured":"Clayton CE, Michels P. Metabolic compartmentation in African trypanosomes. Parasitol Today. 1996;12:465\u201371.","journal-title":"Parasitol Today"},{"key":"3099_CR56","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3389\/fimmu.2017.01714","volume":"8","author":"G Gruenbacher","year":"2017","unstructured":"Gruenbacher G, Thurnher M. Mevalonate metabolism in immuno-oncology. Front Immunol. 2017;8:1714.","journal-title":"Front Immunol"},{"key":"3099_CR57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2018.08.070","volume":"175","author":"Y Xia","year":"2018","unstructured":"Xia Y, Xie Y, Yu Z, Xiao H, Jiang G, Zhou X, Yang Y, Li X, Zhao M, Li L. The mevalonate pathway is a druggable target for vaccine adjuvant discovery. Cell. 2018;175:1059\u201373. e1021.","journal-title":"Cell"},{"key":"3099_CR58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cbpa.2013.06.020","volume":"17","author":"W-c Chang","year":"2013","unstructured":"Chang W-c, Song H, Liu H-w, Liu P. Current development in isoprenoid precursor biosynthesis and regulation. Curr Opin Chem Biol. 2013;17:571\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"3099_CR59","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.3390\/molecules30204065","volume":"30","author":"Y Hu","year":"2025","unstructured":"Hu Y, Yuan Z, Wang Q, Wang Z, Cao J, Wu J, Ren X. Expanding the Terpene Universe: Synthetic Biology and Non-Natural Chemistry in Engineered Microorganisms. Molecules. 2025;30:4065.","journal-title":"Molecules"},{"key":"3099_CR60","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1038\/s41467-024-49483-8","volume":"15","author":"J Perez-Gil","year":"2024","unstructured":"Perez-Gil J, Behrendorff J, Douw A, Vickers CE. The methylerythritol phosphate pathway as an oxidative stress sense and response system. Nat Commun. 2024;15:5303.","journal-title":"Nat Commun"},{"key":"3099_CR61","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1128\/AAC.00987-12","volume":"56","author":"CA Testa","year":"2012","unstructured":"Testa CA, Johnson LJ. A whole-cell phenotypic screening platform for identifying methylerythritol phosphate pathway-selective inhibitors as novel antibacterial agents. Antimicrob Agents Chemother. 2012;56:4906\u201313.","journal-title":"Antimicrob Agents Chemother"},{"key":"3099_CR62","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/plants14101428","volume":"14","author":"R Cheng","year":"2025","unstructured":"Cheng R, Yang S, Wang D, Qin F, Wang S, Meng S. Advances in the biosynthesis of plant terpenoids: models, mechanisms, and applications. Plants. 2025;14:1428.","journal-title":"Plants"},{"key":"3099_CR63","doi-asserted-by":"crossref","first-page":"772994","DOI":"10.3389\/fmicb.2021.772994","volume":"12","author":"X Yang","year":"2021","unstructured":"Yang X, Jiang X, Yan W, Huang Q, Sun H, Zhang X, Zhang Z, Ye W, Wu Y, Govers F. The mevalonate pathway is important for growth, spore production, and the virulence of Phytophthora sojae. Front Microbiol. 2021;12:772994.","journal-title":"Front Microbiol"},{"key":"3099_CR64","doi-asserted-by":"crossref","unstructured":"Dhaniaputri R, Suwono H, Amin M, Lukiati B. Introduction to plant metabolism, secondary metabolites biosynthetic pathway, and in-silico molecular docking for determination of plant medicinal compounds: an overview. In 7th International Conference on Biological Science (ICBS 2021). Atlantis Press; 2022:373\u2013382.","DOI":"10.2991\/absr.k.220406.053"},{"key":"3099_CR65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2010.09.028","volume":"505","author":"HM Miziorko","year":"2011","unstructured":"Miziorko HM. Enzymes of the mevalonate pathway of isoprenoid biosynthesis. Arch Biochem Biophys. 2011;505:131\u201343.","journal-title":"Arch Biochem Biophys"},{"key":"3099_CR66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2014.02.007","volume":"143","author":"B Yeganeh","year":"2014","unstructured":"Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, Freed DH, Hashemi M, Shojaei S, Zeki AA. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther. 2014;143:87\u2013110.","journal-title":"Pharmacol Ther"},{"key":"3099_CR67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jtbi.2017.12.023","volume":"443","author":"F Pool","year":"2018","unstructured":"Pool F, Currie R, Sweby PK, Salazar JD, Tindall MJ. A mathematical model of the mevalonate cholesterol biosynthesis pathway. J Theor Biol. 2018;443:157\u201376.","journal-title":"J Theor Biol"},{"key":"3099_CR68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/bj2950517","volume":"295","author":"M Rohmer","year":"1993","unstructured":"Rohmer M, Knani M, Simonin P, Sutter B, Sahm H. Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem J. 1993;295:517\u201324.","journal-title":"Biochem J"},{"key":"3099_CR69","doi-asserted-by":"crossref","first-page":"661241","DOI":"10.3389\/fimmu.2021.661241","volume":"12","author":"J-y Chen","year":"2021","unstructured":"Chen J-y, Zhou J-k. Immunometabolism: towards a better understanding the mechanism of parasitic infection and immunity. Front Immunol. 2021;12:661241.","journal-title":"Front Immunol"},{"key":"3099_CR70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s43556-025-00321-3","volume":"6","author":"D Cui","year":"2025","unstructured":"Cui D, Yu X, Guan Q, Shen Y, Liao J, Liu Y, Su Z. Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed. 2025;6:72.","journal-title":"Mol Biomed"},{"key":"3099_CR71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","volume":"172","author":"S Bekkering","year":"2018","unstructured":"Bekkering S, Arts RJ, Novakovic B, Kourtzelis I, van der Heijden CD, Li Y, Popa CD, Ter Horst R, van Tuijl J, Netea-Maier RT. Metabolic induction of trained immunity through the mevalonate pathway. Cell. 2018;172:135\u201346. e139.","journal-title":"Cell"},{"key":"3099_CR72","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","volume":"38","author":"J Van den Bossche","year":"2017","unstructured":"Van den Bossche J, O\u2019Neill LA, Menon D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 2017;38:395\u2013406.","journal-title":"Trends Immunol"},{"key":"3099_CR73","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365.","journal-title":"Nat Rev Immunol"},{"key":"3099_CR74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20051129","volume":"203","author":"SE Dunn","year":"2006","unstructured":"Dunn SE, Youssef S, Goldstein MJ, Prod\u2019homme T, Weber MS, Zamvil SS, Steinman L. Isoprenoids determine Th1\/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin. J Exp Med. 2006;203:401\u201312.","journal-title":"J Exp Med"},{"key":"3099_CR75","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00109-019-01784-y","volume":"97","author":"S Acharya","year":"2019","unstructured":"Acharya S, Timilshina M, Chang J-H. Mevalonate promotes differentiation of regulatory T cells. J Mol Med. 2019;97:927\u201336.","journal-title":"J Mol Med"},{"key":"3099_CR76","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/eji.201848011","volume":"49","author":"J Matthias","year":"2019","unstructured":"Matthias J, Zielinski CE. Shaping the diversity of Th2 cell responses in epithelial tissues and its potential for allergy treatment. Eur J Immunol. 2019;49:1321\u201333.","journal-title":"Eur J Immunol"},{"key":"3099_CR77","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/bs.ai.2023.10.002","volume":"160","author":"C Guo","year":"2023","unstructured":"Guo C, Chi H. Immunometabolism of dendritic cells in health and disease. Adv Immunol. 2023;160:83\u2013116.","journal-title":"Adv Immunol"},{"key":"3099_CR78","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nri1839","volume":"6","author":"J Greenwood","year":"2006","unstructured":"Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6:358\u201370.","journal-title":"Nat Rev Immunol"},{"key":"3099_CR79","doi-asserted-by":"publisher","first-page":"15663","DOI":"10.1038\/ncomms15663","volume":"8","author":"B Castella","year":"2017","unstructured":"Castella B, Kopecka J, Sciancalepore P, Mandili G, Foglietta M, Mitro N, Caruso D, Novelli F, Riganti C, Massaia M. The ATP-binding cassette transporter A1 regulates phosphoantigen release and V\u03b39V\u03b42 T cell activation by dendritic cells. Nat Commun. 2017;8:15663.","journal-title":"Nat Commun"},{"key":"3099_CR80","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/cells9061433","volume":"9","author":"T Herrmann","year":"2020","unstructured":"Herrmann T, Fichtner AS, Karunakaran MM. An update on the molecular basis of phosphoantigen recognition by V\u03b39V\u03b42 T cells. Cells. 2020;9:1433.","journal-title":"Cells"},{"key":"3099_CR81","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","volume":"14","author":"S Vavassori","year":"2013","unstructured":"Vavassori S, Kumar A, Wan GS, Ramanjaneyulu GS, Cavallari M, El Daker S, Beddoe T, Theodossis A, Williams NK, Gostick E. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells. Nat Immunol. 2013;14:908\u201316.","journal-title":"Nat Immunol"},{"key":"3099_CR82","doi-asserted-by":"crossref","unstructured":"Workalemahu G, Wang H, Puan K-J, Kuzuyama T, Jones B, Morita C. Metabolic engineering of Salmonella vaccine bacteria to boost human \u03b3\u03b4 T cell immunity (P4538). J Immun. 2013;190:178.125-178.125.","DOI":"10.4049\/jimmunol.190.Supp.178.25"},{"key":"3099_CR83","doi-asserted-by":"crossref","first-page":"1432015","DOI":"10.3389\/fimmu.2024.1432015","volume":"15","author":"L Paniagua-Herranz","year":"2024","unstructured":"Paniagua-Herranz L, Diaz-Tejeiro C, Sanvicente A, Bartolome J, Nieto-Jimenez C, Ocana A. Overcoming limitations for antibody-based therapies targeting \u03b3\u03b4 T (Vg9Vd2) cells. Front Immunol. 2024;15:1432015.","journal-title":"Front Immunol"},{"key":"3099_CR84","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/pharmaceutics16020214","volume":"16","author":"N Khatiwada","year":"2024","unstructured":"Khatiwada N, Hong Z. Potential benefits and risks associated with the use of statins. Pharmaceutics. 2024;16:214.","journal-title":"Pharmaceutics"},{"key":"3099_CR85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0008-8749(03)00148-5","volume":"223","author":"D Sun","year":"2003","unstructured":"Sun D, Fernandes G. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol. 2003;223:52\u201362.","journal-title":"Cell Immunol"},{"key":"3099_CR86","doi-asserted-by":"crossref","first-page":"881825","DOI":"10.3389\/fcimb.2022.881825","volume":"12","author":"GS Saggu","year":"2022","unstructured":"Saggu GS. Apicoplast journey and its essentiality as a compartment for malaria parasite survival. Front Cell Infect Microbiol. 2022;12:881825.","journal-title":"Front Cell Infect Microbiol"},{"key":"3099_CR87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40588-014-0006-7","volume":"1","author":"L Imlay","year":"2014","unstructured":"Imlay L, Odom AR. Isoprenoid metabolism in apicomplexan parasites. Curr Clin Microbiol Rep. 2014;1:37\u201350.","journal-title":"Curr Clin Microbiol Rep"},{"key":"3099_CR88","doi-asserted-by":"crossref","unstructured":"Tschoeke DA, Nunes GL, Jardim R, Lima J, Dumaresq AS, Gomes MR, de Mattos Pereira L, Loureiro DR, Stoco PH, De Matos Gliedes HL. The comparative genomics and phylogenomics of Leishmania amazonensis parasite. Evol Bioinform Online. 2014;10:EBO. S13759.","DOI":"10.4137\/EBO.S13759"},{"key":"3099_CR89","doi-asserted-by":"crossref","first-page":"e1003665","DOI":"10.1371\/journal.ppat.1003665","volume":"9","author":"Z-H Li","year":"2013","unstructured":"Li Z-H, Ramakrishnan S, Striepen B, Moreno SN. Toxoplasma gondii relies on both host and parasite isoprenoids and can be rendered sensitive to atorvastatin. PLoS Pathog. 2013;9:e1003665.","journal-title":"PLoS Pathog"},{"key":"3099_CR90","doi-asserted-by":"crossref","unstructured":"Fan Y-M, Zhang Q-Q, Pan M, Hou Z-F, Fu L, Xu X, Huang S-Y. Toxoplasma gondii sustains survival by regulating cholesterol biosynthesis and uptake via SREBP2 activation. J Lipid Res. 2024;65:100684.","DOI":"10.1016\/j.jlr.2024.100684"},{"key":"3099_CR91","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrmicro3139","volume":"11","author":"I Coppens","year":"2013","unstructured":"Coppens I. Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat Rev Microbiol. 2013;11:823\u201335.","journal-title":"Nat Rev Microbiol"},{"key":"3099_CR92","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1292\/jvms.10-0496","volume":"73","author":"Y Nishikawa","year":"2011","unstructured":"Nishikawa Y, Ibrahim HM, Kameyama K, Shiga I, Hiasa J, Xuan X. Host cholesterol synthesis contributes to growth of intracellular Toxoplasma gondii in macrophages. J Vet Med Sci. 2011;73:633\u20139.","journal-title":"J Vet Med Sci"},{"key":"3099_CR93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fcimb.2019.00036","volume":"9","author":"A Lis","year":"2019","unstructured":"Lis A, Wiley M, Vaughan J, Gray PC, Blader IJ. The activin receptor, Activin-Like Kinase 4, mediates Toxoplasma gondii activation of hypoxia inducible factor-1. Front Cell Infect Microbiol. 2019;9:36.","journal-title":"Front Cell Infect Microbiol"},{"key":"3099_CR94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actatropica.2019.04.018","volume":"195","author":"Y Liu","year":"2019","unstructured":"Liu Y, Zou X, Ou M, Ye X, Zhang B, Wu T, Dong S, Chen X, Liu H, Zheng Z. Toxoplasma gondii Cathepsin C1 inhibits NF-\u03baB signalling through the positive regulation of the HIF-1\u03b1\/EPO axis. Acta Trop. 2019;195:35\u201343.","journal-title":"Acta Trop"},{"key":"3099_CR95","doi-asserted-by":"publisher","unstructured":"Menendez MT, Teygong C, Wade K, Florimond C, Blader IJ. siRNA screening identifies the host hexokinase 2 (HK2) gene as an important hypoxia-inducible transcription factor 1 (HIF-1) target gene in Toxoplasma gondii-infected cells. MBio. 2015;6. https:\/\/doi.org\/10.1128\/mbio.00462-00415.","DOI":"10.1128\/mbio.00462-00415"},{"key":"3099_CR96","doi-asserted-by":"crossref","first-page":"26852","DOI":"10.1074\/jbc.M110.147041","volume":"285","author":"M Wiley","year":"2010","unstructured":"Wiley M, Sweeney KR, Chan DA, Brown KM, McMurtrey C, Howard EW, Giaccia AJ, Blader IJ. Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1\u03b1 subunit via type I activin-like receptor kinase receptor signaling. J Biol Chem. 2010;285:26852\u201360.","journal-title":"J Biol Chem"},{"key":"3099_CR97","doi-asserted-by":"crossref","first-page":"e87594","DOI":"10.1371\/journal.pone.0087594","volume":"9","author":"L Rojo-Arreola","year":"2014","unstructured":"Rojo-Arreola L, Long T, Asarnow D, Suzuki BM, Singh R, Caffrey CR. Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis. PLoS ONE. 2014;9:e87594.","journal-title":"PLoS ONE"},{"key":"3099_CR98","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.3390\/molecules25112602","volume":"25","author":"JC Branco Santos","year":"2020","unstructured":"Branco Santos JC, De Melo JA, Maheshwari S, De Medeiros WMTQ, de Freitas Oliveira JW, Moreno CJ, Mario Amzel L, Gabelli SB, Sousa Silva M. Bisphosphonate-based molecules as potential new antiparasitic drugs. Molecules. 2020;25:2602.","journal-title":"Molecules"},{"key":"3099_CR99","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/pathogens9090689","volume":"9","author":"HJ Hahn","year":"2020","unstructured":"Hahn HJ, Debnath A. In vitro evaluation of farnesyltransferase inhibitor and its effect in combination with 3-hydroxy-3-methyl-glutaryl-coa reductase inhibitor against Naegleria fowleri. Pathogens. 2020;9:689.","journal-title":"Pathogens"},{"key":"3099_CR100","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/AAC.49.5.1679-1687.2005","volume":"49","author":"DC Arruda","year":"2005","unstructured":"Arruda DC, D\u2019Alexandri FL, Katzin AM, Uliana SR. Antileishmanial activity of the terpene nerolidol. Antimicrob Agents Chemother. 2005;49:1679\u201387.","journal-title":"Antimicrob Agents Chemother"},{"key":"3099_CR101","doi-asserted-by":"publisher","first-page":"16453","DOI":"10.1038\/s41598-022-20509-9","volume":"12","author":"SR Prasad","year":"2022","unstructured":"Prasad SR, Kumar P, Mandal S, Mohan A, Chaurasia R, Shrivastava A, Nikhil P, Aishwarya D, Ramalingam P, Gajbhiye R. Mechanistic insight into the role of mevalonate kinase by a natural fatty acid-mediated killing of Leishmania donovani. Sci Rep. 2022;12:16453.","journal-title":"Sci Rep"},{"key":"3099_CR102","doi-asserted-by":"crossref","first-page":"e25770","DOI":"10.4161\/onci.25770","volume":"2","author":"C Riganti","year":"2013","unstructured":"Riganti C, Massaia M. Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone. Oncoimmunology. 2013;2:e25770.","journal-title":"Oncoimmunology"},{"key":"3099_CR103","doi-asserted-by":"crossref","first-page":"2451068","DOI":"10.1002\/eji.202451068","volume":"54","author":"T Herrmann","year":"2024","unstructured":"Herrmann T, Karunakaran MM. Phosphoantigen recognition by V\u03b39V\u03b42 T cells. Eur J Immunol. 2024;54:2451068.","journal-title":"Eur J Immunol"},{"key":"3099_CR104","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.chembiol.2014.06.006","volume":"21","author":"C-HC Hsiao","year":"2014","unstructured":"Hsiao C-HC, Lin X, Barney RJ, Shippy RR, Li J, Vinogradova O, Wiemer DF, Wiemer AJ. Synthesis of a phosphoantigen prodrug that potently activates V\u03b39V\u03b42 T-lymphocytes. Chem Biol. 2014;21:945\u201354.","journal-title":"Chem Biol"},{"key":"3099_CR105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1351\/pac200375020375","volume":"75","author":"M Rohmer","year":"2003","unstructured":"Rohmer M. Mevalonate-independent methylerythritol phosphate pathway for isoprenoid biosynthesis. Elucidation and distribution. Pure Appl Chem. 2003;75:375\u201388.","journal-title":"Pure Appl Chem"},{"key":"3099_CR106","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2174\/156802612799984599","volume":"12","author":"R Jackson","year":"2012","unstructured":"Jackson R, Dowd ES. Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (Dxr): a review of the synthesis and biological evaluation of recent inhibitors. Curr Top Med Chem. 2012;12:706\u201328.","journal-title":"Curr Top Med Chem"},{"key":"3099_CR107","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","volume":"360","author":"MA Missinou","year":"2002","unstructured":"Missinou MA, Borrmann S, Schindler A, Issifou S, Adegnika AA, Matsiegui P-B, Binder R, Lell B, Wiesner J, Baranek T. Fosmidomycin for malaria. Lancet. 2002;360:1941\u20132.","journal-title":"Lancet"},{"key":"3099_CR108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.exppara.2007.02.002","volume":"116","author":"M Clastre","year":"2007","unstructured":"Clastre M, Goubard A, Prel A, Mincheva Z, Viaud-Massuart M-C, Bout D, Rideau M, Velge-Roussel F, Laurent F. The methylerythritol phosphate pathway for isoprenoid biosynthesis in coccidia: presence and sensitivity to fosmidomycin. Exp Parasitol. 2007;116:375\u201384.","journal-title":"Exp Parasitol"},{"key":"3099_CR109","doi-asserted-by":"crossref","first-page":"e70086","DOI":"10.1111\/cbdd.70086","volume":"105","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Wang J, Sun Y, Cheng Y, Wu W. Non-Hydroxamate Inhibitors of IspC Enzyme in the MEP Pathway: Structural Insights and Drug Development Potential. Chem Biol Drug Des. 2025;105:e70086.","journal-title":"Chem Biol Drug Des"},{"key":"3099_CR110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/acs.jmedchem.4c01146","volume":"68","author":"D Willocx","year":"2025","unstructured":"Willocx D, Diamanti E, Hirsch AK. Targeting IspD for Anti-infective and Herbicide Development: Exploring Its Role, Mechanism, and Structural Insights. J Med Chem. 2025;68:886\u2013901.","journal-title":"J Med Chem"},{"key":"3099_CR111","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.2174\/156802611796575867","volume":"11","author":"N Hunter","year":"2011","unstructured":"Hunter N. Isoprenoid precursor biosynthesis offers potential targets for drug discovery against diseases caused by apicomplexan parasites. Curr Top Med Chem. 2011;11:2048\u201359.","journal-title":"Curr Top Med Chem"},{"key":"3099_CR112","doi-asserted-by":"crossref","unstructured":"Chen M, Koszti SG, Bonavoglia A, Maco B, Von Rohr O, Peng H-J, Soldati-Favre D, Kloehn J. Dissecting apicoplast functions through continuous cultivation of Toxoplasma gondii devoid of the organelle. Nat Commun. 2025;16:2095.","DOI":"10.1038\/s41467-025-57302-x"},{"key":"3099_CR113","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1091\/mbc.e02-12-0830","volume":"14","author":"I Coppens","year":"2003","unstructured":"Coppens I, Joiner KA. Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol Biol Cell. 2003;14:3804\u201320.","journal-title":"Mol Biol Cell"},{"key":"3099_CR114","doi-asserted-by":"crossref","first-page":"e1011557","DOI":"10.1371\/journal.ppat.1011557","volume":"20","author":"M Crispim","year":"2024","unstructured":"Crispim M, Verdaguer IB, Hern\u00e1ndez A, Kronenberger T, Fenollar \u00c0, Yamaguchi LF, Alberione MP, Ramirez M, de Oliveira SS, Katzin AM. Beyond the MEP Pathway: A novel kinase required for prenol utilization by malaria parasites. PLoS Pathog. 2024;20:e1011557.","journal-title":"PLoS Pathog"},{"key":"3099_CR115","doi-asserted-by":"crossref","first-page":"1035548","DOI":"10.3389\/fchem.2022.1035548","volume":"10","author":"I Bofill Verdaguer","year":"2022","unstructured":"Bofill Verdaguer I, Sussmann RA, Santiago VF, Palmisano G, Moura GC, Mesquita JT, Yamaguchi LF, Kato MJ, Katzin AM, Crispim M. Isoprenoid alcohols utilization by malaria parasites. Front Chem. 2022;10:1035548.","journal-title":"Front Chem"},{"key":"3099_CR116","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11883-021-00977-6","volume":"23","author":"M Satny","year":"2021","unstructured":"Satny M, Hubacek JA, Vrablik M. Statins and inflammation. Curr Atheroscler Rep. 2021;23:80.","journal-title":"Curr Atheroscler Rep"},{"key":"3099_CR117","doi-asserted-by":"crossref","first-page":"13918","DOI":"10.1074\/jbc.M109.083931","volume":"285","author":"S Miriyala","year":"2010","unstructured":"Miriyala S, Subramanian T, Panchatcharam M, Ren H, McDermott MI, Sunkara M, Drennan T, Smyth SS, Spielmann HP, Morris AJ. Functional characterization of the atypical integral membrane lipid phosphatase PDP1\/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells. J Biol Chem. 2010;285:13918\u201329.","journal-title":"J Biol Chem"},{"key":"3099_CR118","doi-asserted-by":"publisher","unstructured":"Guggisberg AM, Frasse PM, Jezewski AJ, Kafai NM, Gandhi AY, Erlinger SJ, Odom John AR. Suppression of drug resistance reveals a genetic mechanism of metabolic plasticity in malaria parasites. MBio. 2018;9. https:\/\/doi.org\/10.1128\/mbio.01193-01118.","DOI":"10.1128\/mbio.01193-01118"},{"key":"3099_CR119","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/EC.00160-14","volume":"13","author":"AM Guggisberg","year":"2014","unstructured":"Guggisberg AM, Amthor RE, Odom AR. Isoprenoid biosynthesis in Plasmodium falciparum. Eukaryot Cell. 2014;13:1348\u201359.","journal-title":"Eukaryot Cell"},{"key":"3099_CR120","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/ph15121553","volume":"15","author":"T Knak","year":"2022","unstructured":"Knak T, Abdullaziz MA, H\u00f6fmann S, Alves Avelar LA, Klein S, Martin M, Fischer M, Tanaka N, Kurz T. Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities. Pharmaceuticals. 2022;15:1553.","journal-title":"Pharmaceuticals"},{"key":"3099_CR121","doi-asserted-by":"crossref","first-page":"e1012484","DOI":"10.1371\/journal.ppat.1012484","volume":"20","author":"MS Bulloch","year":"2024","unstructured":"Bulloch MS, Huynh LK, Kennedy K, Ralton JE, McConville MJ, Ralph SA. Apicoplast-derived isoprenoids are essential for biosynthesis of GPI protein anchors, and consequently for egress and invasion in Plasmodium falciparum. PLoS Pathog. 2024;20:e1012484.","journal-title":"PLoS Pathog"},{"key":"3099_CR122","doi-asserted-by":"crossref","first-page":"31722","DOI":"10.1021\/acsomega.5c02701","volume":"10","author":"JM Gamrat","year":"2025","unstructured":"Gamrat JM, Orme CL, Mancini G, Burke SJ, Alhthlol LM, Colandrea RC, Figula BC, Tomares DT, Heindl JE, Tomsho JW. Boron-Containing Analogs of Fosmidomycin: Benzoxaborole Derivatives Exhibit Promising Activity Against Resistant Pathogens. ACS omega. 2025;10:31722\u201340.","journal-title":"ACS omega"},{"key":"3099_CR123","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.parint.2018.03.001","volume":"67","author":"K Kadian","year":"2018","unstructured":"Kadian K, Vijay S, Gupta Y, Rawal R, Singh J, Anvikar A, Pande V, Sharma A. Structural modeling identifies Plasmodium vivax 4-diphosphocytidyl-2\u00a0C-methyl-d-erythritol kinase (IspE) as a plausible new antimalarial drug target. Parasitol Int. 2018;67:375\u201385.","journal-title":"Parasitol Int"},{"key":"3099_CR124","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/0972-9062.256562","volume":"55","author":"K Kadian","year":"2018","unstructured":"Kadian K, Vijay S, Rawal R, Singh J, Anvikar A, Pande V, Sharma A. Genetic diversity and structural analysis of 4-diphosphocytidyl-2\u00a0C-methyl-D-erythritol kinase (IspE) from Plasmodium falciparum. J Vector Borne Dis. 2018;55:271\u201381.","journal-title":"J Vector Borne Dis"},{"key":"3099_CR125","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s44321-024-00087-1","volume":"16","author":"M Fraser","year":"2024","unstructured":"Fraser M, Curtis B, Phillips P, Yates PA, Lam KS, Netzel O, van Dooren GG, Ingmundson A, Matuschewski K, McLeod MD. Harnessing cholesterol uptake of malaria parasites for therapeutic applications. EMBO Mol Med. 2024;16:1515.","journal-title":"EMBO Mol Med"},{"key":"3099_CR126","doi-asserted-by":"crossref","first-page":"30804","DOI":"10.1074\/jbc.M703178200","volume":"282","author":"Y Ling","year":"2007","unstructured":"Ling Y, Li Z-H, Miranda K, Oldfield E, Moreno SN. The farnesyl-diphosphate\/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates. J Biol Chem. 2007;282:30804\u201316.","journal-title":"J Biol Chem"},{"key":"3099_CR127","doi-asserted-by":"crossref","unstructured":"Alday PH, Doggett JS. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther. 2017;11:273\u201393.","DOI":"10.2147\/DDDT.S60973"},{"key":"3099_CR128","doi-asserted-by":"crossref","first-page":"e180174","DOI":"10.1590\/0074-02760180174","volume":"113","author":"HB Gabriel","year":"2018","unstructured":"Gabriel HB, Azevedo MF, Kimura EA, Katzin AM. Plasmodium falciparum parasites overexpressing farnesyl diphosphate synthase\/geranylgeranyl diphosphate synthase are more resistant to risedronate. Mem\u00f3rias do Instituto Oswaldo Cruz. 2018;113:e180174.","journal-title":"Mem\u00f3rias do Instituto Oswaldo Cruz"},{"key":"3099_CR129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsinfecdis.1c00296","volume":"8","author":"M Sakari","year":"2022","unstructured":"Sakari M, Laisi A, Pulliainen AT. Exotoxin-targeted drug modalities as antibiotic alternatives. ACS Infect Dis. 2022;8:433\u201356.","journal-title":"ACS Infect Dis"},{"key":"3099_CR130","doi-asserted-by":"crossref","first-page":"29874","DOI":"10.1074\/jbc.M114.601328","volume":"289","author":"V Oganesyan","year":"2014","unstructured":"Oganesyan V, Peng L, Damschroder MM, Cheng L, Sadowska A, Tkaczyk C, Sellman BR, Wu H, Dall\u2019Acqua WF. Mechanisms of neutralization of a human anti-\u03b1-toxin antibody. J Biol Chem. 2014;289:29874\u201380.","journal-title":"J Biol Chem"},{"key":"3099_CR131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1472-6807-7-20","volume":"7","author":"T Sgraja","year":"2007","unstructured":"Sgraja T, Smith TK, Hunter WN. Structure, substrate recognition and reactivity of Leishmania major mevalonate kinase. BMC Struct Biol. 2007;7:20.","journal-title":"BMC Struct Biol"},{"key":"3099_CR132","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1479-5876-11-303","volume":"11","author":"X-L Xu","year":"2013","unstructured":"Xu X-L, Gou W-L, Wang A-Y, Wang Y, Guo Q-Y, Lu Q, Lu S-B, Peng J. Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years? J translational Med. 2013;11:303.","journal-title":"J translational Med"},{"key":"3099_CR133","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1084\/jem.20110039","volume":"208","author":"SC Nair","year":"2011","unstructured":"Nair SC, Brooks CF, Goodman CD, Strurm A, McFadden GI, Sundriyal S, Anglin JL, Song Y, Moreno SN, Striepen B. Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. J Exp Med. 2011;208:1547\u201359.","journal-title":"J Exp Med"},{"key":"3099_CR134","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1124\/dmd.114.057976","volume":"42","author":"L Salphati","year":"2014","unstructured":"Salphati L, Chu X, Chen L, Prasad B, Dallas S, Evers R, Mamaril-Fishman D, Geier EG, Kehler J, Kunta J. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins. Drug Metab Dispos. 2014;42:1301\u201313.","journal-title":"Drug Metab Dispos"},{"key":"3099_CR135","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fimmu.2014.00648","volume":"5","author":"MM Karunakaran","year":"2014","unstructured":"Karunakaran MM, Herrmann T. The V\u03b39V\u03b42 T cell antigen receptor and butyrophilin-3 A1: models of interaction, the possibility of co-evolution, and the case of dendritic epidermal T cells. Front Immunol. 2014;5:648.","journal-title":"Front Immunol"},{"key":"3099_CR136","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3389\/fimmu.2018.00828","volume":"9","author":"L Boutin","year":"2018","unstructured":"Boutin L, Scotet E. Towards deciphering the hidden mechanisms that contribute to the antigenic activation process of human V\u03b39V\u03b42 T cells. Front Immunol. 2018;9:828.","journal-title":"Front Immunol"},{"key":"3099_CR137","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12936-015-1021-8","volume":"14","author":"S Chaorattanakawee","year":"2015","unstructured":"Chaorattanakawee S, Lanteri CA, Sundrakes S, Yingyuen K, Gosi P, Chanarat N, Wongarunkochakorn S, Buathong N, Chann S, Kuntawunginn W. Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia. Malar J. 2015;14:486.","journal-title":"Malar J"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03099-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T08:45:10Z","timestamp":1792140310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03099-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"560"}}